Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Petroff

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Antimicrobial Chemotherapy|May 10, 2021
Perioperative administration of cefazolin and metronidazole in obese and non-obese patients: a pharmacokinetic study in plasma and interstitial fluidChristoph Dorn, David Petroff, Melanie Stoelzel, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 15, 2018
Will the Real Coeliac Disease Please Stand Up? Coeliac Disease Prevalence in the German LIFE Child StudyNorman Händel, Thomas Mothes, David Petroff, et al.
Antibiotics (Basel, Switzerland)|December 29, 2020
Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients-A Controlled Clinical TrialPhilipp Simon, David Petroff, David Busse, et al.
Journal of Clinical Medicine|April 15, 2020
Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic StudyPhilipp Simon, David Busse, David Petroff, et al.
British Journal of Anaesthesia|February 2, 2025
Evaluation of the need for dosing adaptations in obese patients for surgical antibiotic prophylaxis: a model-based analysis of cefazolin pharmacokineticsDavide Bindellini, Philipp Simon, David Busse, et al.
Plos One|August 1, 2012
Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scoresThomas Karlas, Marie Neuschulz, Annett Oltmanns, et al.
The Journal of Antimicrobial Chemotherapy|June 8, 2019
Plasma and tissue pharmacokinetics of fosfomycin in morbidly obese and non-obese surgical patients: a controlled clinical trialChristoph Dorn, David Petroff, Nancy Neumann, et al.
Pharmaceutics|September 28, 2021
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid PharmacokineticsDavid Busse, Philipp Simon, David Petroff, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2019
Plasma and tissue pharmacokinetics of fosfomycin in morbidly obese and non-obese surgical patients: a controlled clinical trialChristoph Dorn, David Petroff, Nancy Neumann, et al.
Annals of Internal Medicine|May 5, 2015
Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization schemeEkkehard Schleussner, Gabriele Kamin, Gregor Seliger, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Antimicrobial Chemotherapy|May 10, 2021
Perioperative administration of cefazolin and metronidazole in obese and non-obese patients: a pharmacokinetic study in plasma and interstitial fluidChristoph Dorn, David Petroff, Melanie Stoelzel, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 15, 2018
Will the Real Coeliac Disease Please Stand Up? Coeliac Disease Prevalence in the German LIFE Child StudyNorman Händel, Thomas Mothes, David Petroff, et al.
Antibiotics (Basel, Switzerland)|December 29, 2020
Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients-A Controlled Clinical TrialPhilipp Simon, David Petroff, David Busse, et al.
Journal of Clinical Medicine|April 15, 2020
Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic StudyPhilipp Simon, David Busse, David Petroff, et al.
British Journal of Anaesthesia|February 2, 2025
Evaluation of the need for dosing adaptations in obese patients for surgical antibiotic prophylaxis: a model-based analysis of cefazolin pharmacokineticsDavide Bindellini, Philipp Simon, David Busse, et al.
Plos One|August 1, 2012
Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scoresThomas Karlas, Marie Neuschulz, Annett Oltmanns, et al.
The Journal of Antimicrobial Chemotherapy|June 8, 2019
Plasma and tissue pharmacokinetics of fosfomycin in morbidly obese and non-obese surgical patients: a controlled clinical trialChristoph Dorn, David Petroff, Nancy Neumann, et al.
Pharmaceutics|September 28, 2021
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid PharmacokineticsDavid Busse, Philipp Simon, David Petroff, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2019
Plasma and tissue pharmacokinetics of fosfomycin in morbidly obese and non-obese surgical patients: a controlled clinical trialChristoph Dorn, David Petroff, Nancy Neumann, et al.
Annals of Internal Medicine|May 5, 2015
Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization schemeEkkehard Schleussner, Gabriele Kamin, Gregor Seliger, et al.
Pageof 13